Cita APA

Caballero Velázquez, T., Pérez-López, O., Yeguas Bermejo, A., Rodríguez Arbolí, E., Colado Varela, E., Sempere Talens, A., & Pérez Simón, J. A. (2023). Prognostic value of measurable residual disease in patients with AML undergoing HSCT: A multicenter study.

Citación estilo Chicago

Caballero Velázquez, Teresa, Olga Pérez-López, Ana Yeguas Bermejo, Eduardo Rodríguez Arbolí, Enrique Colado Varela, Amparo Sempere Talens, y José Antonio Pérez Simón. Prognostic Value of Measurable Residual Disease in Patients With AML Undergoing HSCT: A Multicenter Study. 2023.

Cita MLA

Caballero Velázquez, Teresa, et al. Prognostic Value of Measurable Residual Disease in Patients With AML Undergoing HSCT: A Multicenter Study. 2023.